title: Successful pregnancies in women on renal replacement therapy: report from the EDTA Registry.
abstract: This study reports the geographical incidence of successful pregnancies in women on renal replacement therapy (RRT) and related information on gestation and clinical status of newborns. The impact of successful pregnancy on graft function was assessed by means of a retrospective case-control study. Since 1977 special questionnaires have been sent to each dialysis and transplant centre which reported babies born to mothers on RRT on the yearly centre questionnaire. After 10 years of data collection, a total of 490 pregnancies and 500 babies were available for analysis. A percentage of 88.4 of the babies were born to mothers with a functioning graft, 11.2% to mothers on chronic haemodialysis, and the remaining 0.4% to mothers on CAPD. Almost 50% of all successful pregnancies were reported from the UK. The number of successful pregnancies increased steadily and in parallel with the increasing number of females of childbearing age with a functioning renal transplant. The majority of mothers delivered at age 24-32. For transplanted mothers delivery occurred most commonly during the 3rd and 4th year after successful transplantation. In approximately 85% of cases the duration of pregnancy was shorter than the lower 10th percentile of normal. Birthweight was reduced in accordance with gestational age. Newborn mortality was 1.8%. Fifty-three mothers with a successful pregnancy in 1984-1987 were computer matched with controls according to a number of criteria. The serum creatinine concentration recorded in coded form at the end of each year on the individual EDTA patient questionnaire was used to assess changes in graft function.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Ospedale Pediatrico Bambino Gesú, Istituto di Ricerca Scientifica, Roma, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Rizzoni
authors.forename: J H
authors.initials: JH
authors.lastname: Ehrich
authors.forename: M
authors.initials: M
authors.lastname: Broyer
authors.forename: F P
authors.initials: FP
authors.lastname: Brunner
authors.forename: H
authors.initials: H
authors.lastname: Brynger
authors.forename: W
authors.initials: W
authors.lastname: Fassbinder
authors.forename: W
authors.initials: W
authors.lastname: Geerlings
authors.forename: N H
authors.initials: NH
authors.lastname: Selwood
authors.forename: G
authors.initials: G
authors.lastname: Tufveson
authors.forename: A J
authors.initials: AJ
authors.lastname: Wing
mesh_terms: D000328:Adult; D016022:Case-Control Studies; D003404:Creatinine / Q000097:blood; D005060:Europe / Q000453:epidemiology; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D007676:Kidney Failure, Chronic / Q000097:blood / Q000150:complications / Q000601:surgery; D016030:Kidney Transplantation / Q000009:adverse effects*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000097:blood / Q000453:epidemiology / Q000209:etiology*; D011256:Pregnancy Outcome; D012042:Registries; D012189:Retrospective Studies
chemical_list: D003404:Creatinine